baber/WOPTO huggingface dataset:
Patent FI-965075-A0 (FI)
Inventor: ZIKELI STEFAN
IPC: C08B1/00
Filed: 1996-12-17
Abstract: The invention is concerned with a process for the production of a suspension of cellulose in a liquid, aqueous tertiary amine-oxide, wherein shredded cellulose is mixed with the liquid, aqueous tertiary amine-oxide, said process comprising: (A) contacting the shredded cellulose with the liquid, aqueous tertiary amine-oxide, a first mixture being prepared, and (B) spreading this first mixture mechanically as a layer on a surface and transporting it along this surface while intensively being mixed, until a homogeneous suspension is produced which is removed from the surface, wherein (C) measures (A) and (B) are carried out continuously.
Patent FI-972004-A0 (FI)
Inventor: HOFFMANN HANS-RAINER
IPC: C05G5/14
Filed: 1997-05-12
Abstract: PCT No. PCT/EP95/04204 Sec. 371 Date May 12, 1997 Sec. 102(e) Date May 12, 1997 PCT Filed Oct. 26, 1995 PCT Pub. No. WO96/15660 PCT Pub. Date May 30, 1996In an implantable device for the release of active substances to plants, wherein said device is a ceramic molded article that is interspersed with pores and in which the active substance is distributed in open pores, the pore volume at the time of implantation is dimensioned such that it comprises the total active substance amount to be released, with the kind of the total porosity, its volume, size and scattering as well as the distribution of the pores being determinable within given limits.
Patent FI-972532-A0 (FI)
Inventor: HAARASILTA SAMPSA
IPC: A23L13/60
Filed: 1997-06-13
Abstract: The invention relates to a premix useful in food industry, the premix containing a pulverized plant sterol and a conventional foodstuff raw material. The invention further relates to methods for the manufacture of the premix, to the use of the premix as such and in the manufacture of foodstuffs, and to edible products containing the premix. Bakery products containing the premix of the invention are described in particular.
Patent IL-68816-A0 (IL)
Title: Biocidal or biostatic compositions containing 3-isothiazolones and their preparation
IPC: A61P31/04
Filed: 1983-05-30
Abstract: Biocidal or biostatic compositions containing one or more of a specified range of 3-isothiazolone(s), especially 5-chloro-2-methyl-4-isothiazolin-3-one and/or 2-methyl-4-isothiazolin-3-one, more especially a mixture of the two containing 60-90 weight percent of the chloro compound, having an impurity content (if any) of nitrosamine(s) plus nitrosamine precursor(s) less than 15 ppm, preferably 7.5 ppm, more preferably 3 ppm (on a weight basis) of the 3-isothiazolone(s) and nitrosating agent(s), such as nitrate salt ringstabiliser(s) capable of converting the precursor(s) to nitrosamine(s). The compositions can be made by processes involving purification of intermediate product(s) by ion exchange, recrystallization and/or solvent extraction and/or involving the use of nucleophilic scavenger(s) in the preparation of intermediate product(s) and/or involving the use of certain mercapto-amide(s) as intermediate products. Cosmetic (including toiletry) and pharmaceutical preparations containing the compositions are also disclosed.
Patent IL-75213-A0 (IL)
Title: Split-image optical viewing instrument
IPC: G02B23/16
Filed: 1985-05-16
Abstract: An optical viewing instrument, comprises a housing (2) including an eyepiece (12) for viewing a field; a beam splitter (24) within the housing (2) and splitting the field viewed via the eyepiece (12) into a first image for direct viewing by a first observer, and a second image for viewing by a second observer; and a solid state image converter (30) within the housing (2) located to receive the second image and to convert it to electrical signals for reproduction at a remote location.
Patent IL-76187-A0 (IL)
Title: Anti-urokinase monoclonal antibody,matrix bearing it,test method and biochemical test kits which use it
IPC: A61K39/395
Filed: 1985-08-26
Abstract: A class of new IgG1 monoclonal antibodies, directed to an epitope on human urokinase, which selectively bind to high molecualr weight urokinase (54,000), or a single-chain precursor thereof, without binding to low molecular weight urokinase (33,000) have an affinity constant for urokinase which is suitable for use in an immono-adsorption-based purification system and does not impair the enzymatic activity of urokinase. This antibody is also useful in immunoassays.
Patent IL-85661-A0 (IL)
Title: 1-alkyl substituted benzimidazole derivatives,their preparation and pharmaceutical compositions containing them
IPC: C07D403/12
Filed: 1988-03-08
Abstract: Novel 1-alkyl substituted benzimidazole derivatives of formula <CHEM>  wherein -A<1>=A<2>-A<3>=A<4>- is a bivalent radical having the formula -CH=CH-CH=CH- (a-1), -N=CH-CH=CH- (a-2), -CH=N-CH=CH- (a-3), -CH=CH-N=CH- (a-4), -CH=CH-CH=N- (a-5), -N=CH-N=CH- (a-6), or -CH=N-CH=N- (a-7);      B is NR<3>, CH2, O, S, SO or SO2; L is hydrogen, C1-6alkylcarbonyl, C1-6alkylsulfonyl, C1-6alkyloxycarbonyl, Ar<2>-C1-6alkyloxycarbonyl, Ar<2>-carbonyl, Ar<2>-sulfonyl, C3-6cycloalkyl, C2-6alkenyl optionally substituted with Ar<2>, C1-12alkyl, a radical of formula -Alk-R<4> (b-1), -Alk-Y-R<5> (b-2), -Alk-Z<1>-C(X)-Z<2>-R<6> (b-3), or -CH2-CHOH-CH2-O-R<7> (b-4); the pharmaceutically acceptable acid addition salts and stereochemically isomeric forms thereof, which compounds are anti-allergic agents; pharmaceutical compositions containing such compounds as an active ingredient and methods of preparing said compounds and pharmaceutical compositions.
Patent IL-97574-A0 (IL)
Title: Novel ascorbic acid derivatives
IPC: A61P9/00
Filed: 1991-03-17
Abstract: This invention relates to derivatives of certain 3,4-dihydroxy-2,5-dihydrofuran-5-ones, to the intermediates and processes useful for their preparation, to their free-radical scavenger and cellular protective properties, and to their end-use application as therapeutic agents.
Patent FI-20002059-A0 (FI)
Inventor: SEVOLA MAURI
IPC: H02K5/173
Filed: 2000-09-18
Abstract: A lubricant discharge device for discharging lubricant from a bearing housing (1) of an electric motor includes a tubular element (3) consisting of components (3a, 3b) arranged at a lubricant discharge opening (2) in the bearing housing. A piston (4) is arranged inside the tubular element (3) being connected to an arm section (5). The tubular element comprises a first end (3d) placed at the grease discharge opening and a second end (3c) that is opposite to the first end and is situated at the outer edge of an end shield of the electric motor. An opening (6) is provided in the casing of the tubular element close to the second end (3c) of the tubular element, and a closing means (7) is arranged inside the tubular element to open and close the opening (6).
Patent FI-20025029-A0 (FI)
Inventor: KETTUNEN JONI
IPC: A61B5/0205
Filed: 2002-05-29
Abstract: The present invention describes a method of tracking minute ventilation from R-R intervals that are based on the acquisition of ECG signal. Sub-methods (RDF1), which are mainly based on heart rate variability, are used, wherein the respiratory frequency is determined from a pattern of rhythmic changes in heart beat data. The sub-methods (RDF1-n) are combined using an expert function, wherein each sub-method (RDF1-n) determines an estimate of the respiratory frequency.
Patent FI-20031663-A0 (FI)
Inventor: NORDLUND HENRI RAINER
IPC: C07K14/465
Filed: 2003-11-14
Abstract: Two circularly permuted avidin monomers arc designed. The circularly permuted monomers are fused and the resulting fusion peptides (dcAvd) form a pseudo-tetrameric dual-chain avidin, which is biologically active in biotin binding and shows similar structural characteristics as wild-type avidin. The dcAvd makes the development of dual-affinity avidins possible by allowing the adjustment of the ligand binding properties in the half of the binding sites differently than in the rest of the sites. The present invention provides further a single-chain avidin (scAvd) where two dcAvd-molecules are fused together via a linker to form a single polypeptide with four binding sites for biotin or other ligand.
Patent FI-20106157-A0 (FI)
Inventor: KUITTINEN JARNO
IPC: E21B/
Filed: 2010-11-04
Abstract: A rock drilling rig and to a method for transmission thereof is provided. The rock drilling rig includes a carriage that is movable by drive equipment in a mine. The rock drilling rig includes a hydraulic drilling system for which pressure energy is generated by a hydraulic pump. The rock drilling rig is electrically driven and includes an electric motor that is connected to drive both the drive equipment and the hydraulic drilling system. The mechanical drive transmission included in the drive equipment and the hydraulic pump of the hydraulic drilling system may be connected and disconnected independently of one another by means of clutches.
Patent IL-102299-A0 (IL)
Title: Alumina coated sintered body and method for the preparation thereof
IPC: C04B41/88
Filed: 1992-06-24
Abstract: According to the invention there is now provided a sintered hard material body at least partly coated with at least one 0.5-20  mu m wear resistant ceramic oxide coating being <80% thicker in the edges than on the flat surfaces. The oxide coating exhibits a grain size ( DIAMETER ) in  mu m for which: <MATH> where x is coating thickness in  mu m on at least 80% of the flat surfaces of the body,     k = 0.5, preferably 0.3 and     1 = 2  mu m for 4</=x<20 and 1=0 for 0.5<x<4. The oxide coating is achieved by using a deposition process in which the body is in contact with a gas containing one or more halides of a metal or metals and a hydrolysing and/or oxidizing agent forming the metal oxides and with an additional reactant (dopant) of sulphur, phosphorus, selenium, tellurium, arsenic, antimony and/or bismuth and/or compounds thereof. The temperature during deposition is in the range of 800-1000 DEG C, preferably 850-970 DEG C, and the volume concentration of the additional reactant is 0.25-3, preferably 0.3-1 % of the total gas volume.
Patent IL-109736-A0 (IL)
Title: Digital receiver for variable symbol rate communications
IPC: H04L7/02
Filed: 1994-05-23
Abstract: A digital receiver (20) includes a tuner (24) and a demodulator (30) that obtains a baseband signal (36) carried in a received analog signal (22). A first sampler (46) operates at a preselected fixed asynchronous sampling rate on the baseband component to produce a first sampler output (48). A controllable digital filter (50) resamples the first sampler output to produce a filter output with a selectable resampling rate. The resampled output is time-position locked to baseband signal epochs. The resampling is processed to ascertain the bit stream of the baseband signal. The controllable filter sampling rate is automatically varied to correspond to the data rate of the baseband signal, so that the sampling rate of the first sampler need not change. Initial signal acquisition is achieved by operating the receiver as a frequency spectrum analyzer. A single signal-carrying band (66) is identified and demodulated, and a menu (72) carried on a transport layer (68) is read. This menu provides the center frequencies and bandwidths for all of the signals within an available frequency range, so that the receiver can be reconfigured for any desired signal. Changes in transmission characteristics of the signal can later be accommodated seamlessly by reading a change notice (74) transmitted in the transport layer and reconfiguring the receiver for the new transmission characteristics. <IMAGE>
Patent IL-113077-A0 (IL)
Title: New combination of a beta - receptor blocker and alocal anaesthetic
IPC: A61K45/06
Filed: 1995-03-22
Abstract: PCT No. PCT/SE95/00314 Sec. 371 Date Apr. 28, 1995 Sec. 102(e) Date Apr. 28, 1995 PCT Filed Apr. 24, 1995 PCT Pub. No. WO95/27511 PCT Pub. Date Oct. 19, 1995New combination of a  beta -receptor blocker, an enantiomer thereof, and a local anesthetic, administered simultaneously or sequentially, giving excellent pain relief. Also comprised in the invention is the use of a non-selective  beta -receptor blocker alone, especially a non-selective  beta -receptor blocker giving pain relief.
Patent IL-115384-A0 (IL)
Title: 2,7-Substituted octahydro-1-h-pyrido Ú1,2-a¾ pyrazine derivatives
IPC: A61K31/535
Filed: 1995-09-21
Abstract: PCT No. PCT/IB95/00689 Sec. 371 Date Mar. 26, 1997 Sec. 102(e) Date Mar. 26, 1997 PCT Filed Aug. 24, 1995 PCT Pub. No. WO96/10571 PCT Pub. Date Apr. 11, 1996Substituted pydrido[1,2-a]pyrazines of general formula I wherein Ar and Ar1 represent various carbocyclic and heterocyclic aromatic rings; A represents O, S, SO, SO2, C=O, CHOH, or -(CR3R4) and n is 0-2 as well as precursors thereto are ligands for dopamine receptor subtypes within the body and are therefore useful in the treatment of disorders of the dopamine system.    <IMAGE>  I
Patent IL-117585-A0 (IL)
Title: Interpenetrating polymer networks for contact lens production
IPC: C08G18/63
Filed: 1996-03-20
Abstract: The present invention is directed to an interpenetrating polymer network comprised of a polyurea network interpenetrated with a polyacrylic network and the article of manufacture, such as a contact lens, made therefrom.
Patent IL-127526-A0 (IL)
Title: Payphone metering in a wireless telephone system
IPC: H04M17/02
Filed: 1997-06-11
Abstract: The wireless system includes one or more payphones from which users may initiate payphone calls. A mobile switching center connects telephone calls initiated from wireless payphones to external telephone systems such as the public switch telephone network (PSTN). To meter charges incurred during the telephone call within an external system, the external system transmits periodic metering pulses to the mobile switching center. Each pulse is representative of a predetermined amount of money associated with the telephone call. The rate at which the periodic pulses are transmitted to the mobile switching center depends upon the current billing rate and may be affected by, for example, the time of day. Rather than the forwarding all of the metering pulses to the wireless payphone, therefore consuming a portion of the bandwidth available for wireless telephone calls, the mobile switching center calculates a steady state billing rate from the metering pulses, then transmits only the steady state billing rate to the wireless payphone. The ireless payphone calculates charges associated with the telephone call based upon the steady state billing rate and displays the resulting charges to the user. Once the mobile switching center has transmitted the steady state billing rate signal to the wireless payphone, a second steady state billing signal is not transmitted unless and until the billing rate for the telephone call changes as detected from a change in the rate of received metering pulses from the external system. In one arrangement, the mobile switching center filters out all metering pulses and transmits only steady state billing rate signals to the wireless payphone. In another arrangement, the mobile switching center transmits metering pulse signals to the wireless payphone until the steady state rate has been determined, then transmits a single steady state billing rate signal. If the billing rate changes, the mobile switching center again forwards metering pulses to the wireless payphone until the new steady state billing rate can be determined.
Patent IL-129583-A0 (IL)
Title: Polyurethane/urea compositions
IPC: C08G18/50
Filed: 1999-04-25
Abstract: The invention relates to polyaldimines of formula [1] and their use within moisture curable one part polyurea compositions.wherein j is an integer of 3 to 30 and R2 is unsubstituted homocyclic or heterocyclic aryl radical or alkyl, alkoxy, alkylthio or halogen substituted homocyclic or heterocyclic aryl radical.
Patent IL-145319-A0 (IL)
Title: Highly parallel map decoder
IPC: G06F11/10
Filed: 2000-03-30
Abstract: A coded signal is decoded using maximum a posteriori (MAP) decoding. Several MAP engines (104) each decodes a corresponding different portion (102) of a frame (100) of symbol estimates. The tail portion (103) of each portion is decoded into an initialization value (105) for the adjoining map engine (104). The resulting sections (108) of soft (or hard) decisions are output to make a decision frame (106).
Patent IL-146333-A0 (IL)
Title: Robust interconnect structure
IPC: H01L21/60
Filed: 2000-05-15
Abstract: A structure comprising a layer of copper, a barrier layer, a layer of AlCu, and a pad-limiting layer, wherein the layer of AlCu and barrier layer are interposed between the layer of copper and pad-limiting layer.
Patent IL-153414-A0 (IL)
Title: Method for the production of trioxime derivatives
IPC: C07C249/06
Filed: 2001-07-04
Abstract: The present invention relates to a process for preparing trioxime derivatives of the formula I in which the substituents R<SUP>1 </SUP>and R<SUP>2 </SUP>are identical or different and each is cyano, alkyl, haloalkyl or cycloalkyl, and R<SUP>3 </SUP>and R<SUP>4 </SUP>are identical or different and each is alkyl, haloalkyl, cycloalkyl, alkylcarbonyl or arylalkyl, by the following reaction steps in water without isolation of the intermediates: A) nitrosation of 1,3-diketones of the formula II to give monooximes of the formula III, B) oximation of III with hydroxylamine derivatives of the formula IV <?in-line-formulae description="In-line Formulae" end="lead"?>H<SUB>2</SUB>N-OR<SUP>3'</SUP> IV<?in-line-formulae description="In-line Formulae" end="tail"?> in which R<SUP>3'</SUP> is hydrogen or a group R<SUP>3 </SUP>to give bisoximes of the formula V, C) alkylation of V with alkylating agents or acylation of V with acylating agents to give compounds of the formula VI and D) subsequent oximation of VI with hydroxylamine to give compounds of the formula I.
Patent IL-158474-A0 (IL)
Title: Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
IPC: A61K31/711
Filed: 2002-04-19
Abstract: This invention relates to novel room-temperature process for obtaining calcium phosphate, in particular hydroxyapatite, coatings and microspheres that encapsulate drugs, proteins, genes, DNA for therapeutical use. The coatings and microspheres are designed to perform a defined biological function related to drug delivery, such as gene therapy through gene delivery. A novel method for encapsulation, and subsequent controlled release of therapeutically active agents from such biofunctional coatings and microspheres is disclosed. Such coatings and microspheres are useful for side-effects free, long-term, targeted, controlled release and delivery of drugs, proteins, DNA, and other therapeutic agents.
Patent IL-166787-A0 (IL)
Title: A delivery system and a manufacturing process of adelivery system
IPC: A61F6/14
Filed: 2003-09-04
Abstract: The invention relates to a delivery system comprising a body construction (7) and at least one capsule (8) containing a pharmaceutical composition, said capsule having at least a first end and a second end. According to the invention the body construction (7) has at least two locking parts (9, 10), each locking part having a surface adapted to face and cover one of the at least first and second ends of the capsule (8), and in that the capsule (8) is mounted between said at least two locking parts (9, 10). The invention further relates to one manufacturing process of a delivery system, said system comprising a body construction and at least one capsule containing a pharmaceutical composition. <IMAGE>
Patent IL-180824-A0 (IL)
Title: A method of providing a gap indication during a sticky assignment
IPC: H04W76/06
Filed: 2007-01-21
Abstract: A method and a corresponding apparatus for data transmission during a sticky assignment of a transmit resource in a communication system is described, the method comprising determining if any transmit data packets are queued and ready to be transmitted, transmitting the data packets using the assigned resource, if it is determined that one or more data packets are ready for transmission and transmitting a predetermined erasure signature packet using the assigned resource, if it is determined that no data packets are ready for transmission. Also the corresponding reception method and apparatus arc described.
Patent IL-193097-A0 (IL)
Title: Methods and kits for early detection of cancer or predisposition thereto
Filed: 2008-07-28
Abstract: Methods and kits for diagnosing cancer or a pre-malignant lesion by determining the presence and/or level of circulating CD24 of a subject are provided. Also provided are methods and kits for determining if a subject is predisposed to gastrointestinal cancer by the determining the presence or absence, in a homozygous or heterozygous form of cancer associated genotype(s) in the CD24 and/or APC nucleic acid sequences. Also provided are methods and kits for monitoring efficacy of cancer therapy by determining the presence and/or level of circulating CD24 of a subject.
Patent IL-195378-A0 (IL)
Title: Radioactive substituted heterocycle derivative and diagnostic agent for alzheimer's containing it
Filed: 2008-11-19
Abstract: The present invention provides a compound which has affinity with amyloid, shows sufficiently rapid clearance from normal tissues and is suppressed in toxicity such as mutagencity. Provided is a compound represented by the following formula (1) or a salt thereof:   
wherein A 1 , A 2 , A 3  and A 4  independently represents a carbon or nitrogen; R 1  is a halogen substituent; R 2  is a halogen substituent; and m is an integer of 0 to 2, provided that at least one of R 1  and R 2  is a radioactive halogen substituent, at least one of A 1 , A 2 , A 3  and A 4  represents a carbon, and R 1  binds to a carbon represented by A 1 , A 2 , A 3  or A 4  as well as a low-toxic diagnostic agent comprising a compound represented by the preceding formula or a salt thereof.
Patent IL-196683-A0 (IL)
Title: System and method for communicatiing using a plurality of tdma mesh networks having efficient bandwidth use
IPC: H04W16/14
Filed: 2009-01-22
Abstract: In accordance with a non-limiting example of the present invention, a communications system includes a plurality of Time Division Multiple Access (TDMA) mesh networks, each comprising a plurality of wireless nodes, each having a transmitter and receiver that communicate on a primary and at least one secondary frequency, and communicate using a TDMA epoch that is divided into at least a beacon interval using the primary frequency and a digital data interval using both the primary and secondary frequencies. The wireless nodes are operative for allocating a secondary frequency usage of a digital data interval for a TDMA mesh network to fall into an unused portion of the secondary frequency usage of another TDMA mesh network.
Patent IL-197456-A0 (IL)
Title: Method and system for determining a threat against a border
Filed: 2009-03-08
Abstract: A method for determining a threat against a border from objects crossing or trying to cross said border. Said method includes at least the steps of segmenting the border into border elements of uniform terrain features, infrastructure and weather conditions, collecting data of incidents occurring along a given border element, determining a threat potential for said border element, determining a protection factor for the border element, and determining a threat against the border element from the threat potential and protection factor. The method may be used for warning about an increased threat to a border, wherein the threat is compared with a threat value threshold. If the threat exceeds the threat value threshold, an alarm is issued. The method may also be used for allocating protective measures along a border.
Patent IL-198877-A0 (IL)
Title: Fail-safe vacuum actuated valve for high pressure delivery systems
Filed: 2009-05-21
Abstract: A high pressure storage and delivery system having a fail-safe vacuum actuated valve is provided. In particular, through the innovative design of the vacuum actuated check valve, the system can accommodate up to three times the volume of product in similar size cylinders.